Combination of empagliflozin and citalopram effective against major depressive disorder: Study
Iran: Combination therapy of empagliflozin and citalopram is effective in reducing symptom severity in patients with major depressive disorder, a randomized double-blind, placebo-controlled clinical trial has shown. Empagliflozin is a blood sugar-lowering drug that works as a highly selective and potent inhibitor of sodium-glucose co-transporter 2 (SGLT2). “This average reduction in symptom severity was statistically […]